Thrivent Financial for Lutherans Makes New Investment in Astrana Health, Inc. (NASDAQ:ASTH)

Thrivent Financial for Lutherans purchased a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the third quarter, Holdings Channel reports. The fund purchased 32,617 shares of the company’s stock, valued at approximately $1,890,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. SteelPeak Wealth LLC bought a new position in Astrana Health during the third quarter valued at about $39,398,000. NorthCrest Asset Manangement LLC bought a new position in Astrana Health during the third quarter worth about $26,704,000. Principal Financial Group Inc. bought a new stake in Astrana Health during the 3rd quarter worth approximately $13,383,000. F M Investments LLC acquired a new stake in shares of Astrana Health in the 3rd quarter valued at $11,738,000. Finally, Diamond Hill Capital Management Inc. acquired a new stake in shares of Astrana Health during the third quarter worth $8,245,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Wall Street Analyst Weigh In

ASTH has been the topic of a number of research reports. BTIG Research boosted their price target on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. TD Cowen initiated coverage on Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 target price on the stock. Truist Financial boosted their price target on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Robert W. Baird increased their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Finally, KeyCorp initiated coverage on shares of Astrana Health in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Astrana Health presently has a consensus rating of “Buy” and a consensus target price of $65.17.

Astrana Health Trading Up 0.9 %

ASTH opened at $42.86 on Friday. The company’s 50 day moving average is $53.37 and its 200-day moving average is $47.95. The company has a market cap of $2.41 billion, a P/E ratio of 32.97, a PEG ratio of 1.97 and a beta of 1.24. Astrana Health, Inc. has a 1-year low of $32.32 and a 1-year high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. The firm had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same quarter in the prior year, the business earned $0.47 earnings per share. Equities research analysts predict that Astrana Health, Inc. will post 1.17 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.